Southport Acquisition Corp. II Announces Pricing of $200,000,000 Initial Public Offering

Southport Acquisition Corp. II (NYSE: PORT.U) (the “Company”) today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The Company’s units are ...
PR Newswire

Ives Ultra AI Opportunities Inc. (NYSE: IVAI) Announces Pricing of $200 Million Initial Public Offering

Ives Ultra AI Opportunities Inc. ("IVAI") today announced the pricing of its initial public offering of 20,000,000 shares of ...

Initial Public Offerings (IPOs)

IPOs are how most previously private companies become publicly traded on the stock market. Browse Investopedia’s ...
The Manila Times

Accelevation Announces Pricing of Initial Public Offering

Accelevation Holdings Corp. ('Accelevation”) today announced the pricing of its initial public offering of 30,000,000 shares of its Class A common stock at a public offering price of $18.00 per share, ...
PYMNTS.com

Zilch Looks to Take BNPL Firm Public in 2027

U.K. FinTech Zilch is reportedly in discussions with banks as it prepares to go public. The company, whose offerings include ...
PR Newswire

Bluerock Acquisition Corp. II Announces Pricing of $150 Million Initial Public Offering

Bluerock Acquisition Corp. II (the "Company") today announced the pricing of its initial public offering of 15,000,000 units ...
Reuters

Cerebras prices IPO at $185 per share to raise $5.55 billion

NEW YORK, May 13 (Reuters) - Cerebras Systems priced its U.S. initial public offering at $185 per share on Wednesday, above the top end of its indicated price range, the company said, confirming a ...
Business Wire

ŌURA Announces Launch of Initial Public Offering

URA, a leading health intelligence platform and maker of the world’s smallest smart ring, today announced that it has launched its initial public offering ...
Legal Desire

Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering

ADARx Pharmaceuticals, Inc., a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, has ...

Tankmaker KNDS Considers Delaying Initial Public Offering

KNDS NV and its owners are considering pushing back its initial public offering, people familiar with the matter said, increasing the likelihood that one of Europe’s most-anticipated listings will be ...